Literature DB >> 16264195

Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1.

Nicole Wagner1, Kay-Dietrich Wagner, Heinz Theres, Christoph Englert, Andreas Schedl, Holger Scholz.   

Abstract

The formation of intramyocardial blood vessels is critical for normal heart development and tissue repair after infarction. We report here expression of the Wilms' tumor gene-1, Wt1, in coronary vessels, which could contribute to the defective cardiac vascularization in Wt1-/- mice. Furthermore, the high-affinity neurotrophin receptor TrkB, which is expressed in the epicardium and subepicardial blood vessels, was nearly absent from Wt1-deficient hearts. Activation of Wt1 in an inducible cell line significantly enhanced TrkB expression. The promoter of NTRK2, the gene encoding TrkB, was stimulated approximately 10-fold by transient cotransfection of a Wt1 expression construct. The critical DNA-binding site for activation of the NTRK2 promoter by Wt1 was delineated by DNase I footprint analysis and electrophoretic mobility shift assay. Transgenic experiments revealed that the identified Wt1 consensus motif in the NTRK2 promoter was necessary to direct expression of a reporter gene to the epicardium and the developing vasculature of embryonic mouse hearts. Finally, mice with a disrupted Ntrk2 gene lacked a significant proportion of their intramyocardial blood vessels. These findings demonstrate that transcriptional activation of the TrkB neurotrophin receptor gene by the Wilms' tumor suppressor Wt1 is a crucial mechanism for normal vascularization of the developing heart.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16264195      PMCID: PMC1276736          DOI: 10.1101/gad.346405

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  48 in total

1.  Presence of WT1, the Wilm's tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein.

Authors:  M R Ladomery; J Slight; S Mc Ghee; N D Hastie
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

2.  A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system.

Authors:  Nicole Wagner; Kay-Dietrich Wagner; Annette Hammes; Karin M Kirschner; Valerie P Vidal; Andreas Schedl; Holger Scholz
Journal:  Development       Date:  2005-02-16       Impact factor: 6.868

3.  The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin.

Authors:  S B Lee; K Huang; R Palmer; V B Truong; D Herzlinger; K A Kolquist; J Wong; C Paulding; S K Yoon; W Gerald; J D Oliner; D A Haber
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

Review 4.  The biology of vascular endothelial growth factors.

Authors:  Tuomas Tammela; Berndt Enholm; Kari Alitalo; Karri Paavonen
Journal:  Cardiovasc Res       Date:  2005-02-15       Impact factor: 10.787

5.  Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors.

Authors:  Pouneh Kermani; Dahlia Rafii; David K Jin; Paul Whitlock; Wendy Schaffer; Anne Chiang; Loic Vincent; Matthias Friedrich; Koji Shido; Neil R Hackett; Ronald G Crystal; Shahin Rafii; Barbara L Hempstead
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

6.  YAC transgenic analysis reveals Wilms' tumour 1 gene activity in the proliferating coelomic epithelium, developing diaphragm and limb.

Authors:  A W Moore; A Schedl; L McInnes; M Doyle; J Hecksher-Sorensen; N D Hastie
Journal:  Mech Dev       Date:  1998-12       Impact factor: 1.882

7.  The Wilms tumor suppressor gene wt1 is required for development of the spleen.

Authors:  U Herzer; A Crocoll; D Barton; N Howells; C Englert
Journal:  Curr Biol       Date:  1999 Jul 29-Aug 12       Impact factor: 10.834

8.  The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1.

Authors:  Nicole Wagner; Kay-Dietrich Wagner; Yiming Xing; Holger Scholz; Andreas Schedl
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

9.  Experimental studies on the spatiotemporal expression of WT1 and RALDH2 in the embryonic avian heart: a model for the regulation of myocardial and valvuloseptal development by epicardially derived cells (EPDCs).

Authors:  J M Pérez-Pomares; A Phelps; M Sedmerova; R Carmona; M González-Iriarte; R Muñoz-Chápuli; A Wessels
Journal:  Dev Biol       Date:  2002-07-15       Impact factor: 3.582

Review 10.  Myocardial angiogenesis.

Authors:  Eiji Toyota; Toshiro Matsunaga; William M Chilian
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

View more
  58 in total

Review 1.  Epicardial-myocardial signaling directing coronary vasculogenesis.

Authors:  Harold E Olivey; Eric C Svensson
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

2.  The Wilms' tumor suppressor WT1 is associated with melanoma proliferation.

Authors:  Nicole Wagner; John Panelos; Daniela Massi; Kay-Dietrich Wagner
Journal:  Pflugers Arch       Date:  2007-10-03       Impact factor: 3.657

Review 3.  Role of the Wilms' tumour transcription factor, Wt1, in blood vessel formation.

Authors:  Holger Scholz; Kay-Dietrich Wagner; Nicole Wagner
Journal:  Pflugers Arch       Date:  2008-12-04       Impact factor: 3.657

Review 4.  Cardiovascular actions of neurotrophins.

Authors:  Andrea Caporali; Costanza Emanueli
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 5.  Coronary vessel development and insight towards neovascular therapy.

Authors:  Nicola Smart; Karina N Dubé; Paul R Riley
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

6.  Genetic variant of BDNF (Val66Met) polymorphism attenuates stroke-induced angiogenic responses by enhancing anti-angiogenic mediator CD36 expression.

Authors:  Luye Qin; Eunhee Kim; Rajiv Ratan; Francis S Lee; Sunghee Cho
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

7.  Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin.

Authors:  Ofelia M Martínez-Estrada; Laura A Lettice; Abdelkader Essafi; Juan Antonio Guadix; Joan Slight; Víctor Velecela; Emma Hall; Judith Reichmann; Paul S Devenney; Peter Hohenstein; Naoki Hosen; Robert E Hill; Ramón Muñoz-Chapuli; Nicholas D Hastie
Journal:  Nat Genet       Date:  2009-12-20       Impact factor: 38.330

8.  An adaptive role for BDNF Val66Met polymorphism in motor recovery in chronic stroke.

Authors:  Luye Qin; Deqiang Jing; Sarah Parauda; Jason Carmel; Rajiv R Ratan; Francis S Lee; Sunghee Cho
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

9.  Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model.

Authors:  Mathieu Blais; Philippe Lévesque; Sabrina Bellenfant; François Berthod
Journal:  Tissue Eng Part A       Date:  2013-03-26       Impact factor: 3.845

10.  Meta-coexpression conservation analysis of microarray data: a "subset" approach provides insight into brain-derived neurotrophic factor regulation.

Authors:  Tamara Aid-Pavlidis; Pavlos Pavlidis; Tõnis Timmusk
Journal:  BMC Genomics       Date:  2009-09-08       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.